In fact, enzalutamide antagonizes AR to inhibit the androgen-induced proliferation of metastatic, castration-resistant prostate cancer cells, and enzalutamide induces apoptosis for prostate cancer cells in which AR is highly expressed35. The gene discussed is AR; the disease is prostate cancer.